Skip to content

Research at St Andrews

Inhibitors of the interferon response enhance virus replication in vitro.

Research output: Contribution to journalArticlepeer-review

Author(s)

School/Research organisations

Abstract

Virus replication efficiency is influenced by two conflicting factors, kinetics of the cellular interferon (IFN) response and induction of an antiviral state versus speed of virus replication and virus-induced inhibition of the IFN response. Disablement of a virus's capacity to circumvent the IFN response enables both basic research and various practical applications. However, such IFN-sensitive viruses can be difficult to grow to high-titer in cells that produce and respond to IFN. The current default option for growing IFN-sensitive viruses is restricted to a limited selection of cell-lines (e.g. Vero cells) that have lost their ability to produce IFN. This study demonstrates that supplementing tissue-culture medium with an IFN inhibitor provides a simple, effective and flexible approach to increase the growth of IFN-sensitive viruses in a cell-line of choice. We report that IFN inhibitors targeting components of the IFN response (TBK1, IKK2, JAK1) significantly increased virus replication. More specifically, the JAK1/2 inhibitor Ruxolitinib enhances the growth of viruses that are sensitive to IFN due to (i) loss of function of the viral IFN antagonist (due to mutation or species-specific constraints) or (ii) mutations/host cell constraints that slow virus spread such that it can be controlled by the IFN response. This was demonstrated for a variety of viruses, including, viruses with disabled IFN antagonists that represent live-attenuated vaccine candidates (Respiratory Syncytial Virus (RSV), Influenza Virus), traditionally attenuated vaccine strains (Measles, Mumps) and a slow-growing wild-type virus (RSV). In conclusion, supplementing tissue culture-medium with an IFN inhibitor to increase the growth of IFN-sensitive viruses in a cell-line of choice represents an approach, which is broadly applicable to research investigating the importance of the IFN response in controlling virus infections and has utility in a number of practical applications including vaccine and oncolytic virus production, virus diagnostics and techniques to isolate newly emerging viruses.
Close

Details

Original languageEnglish
Article numbere112014
Number of pages8
JournalPLoS One
Volume9
Issue number11
DOIs
Publication statusPublished - 12 Nov 2014

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice

    Vasou, A., Paulus, C., Narloch, J., Gage, Z. O., Rameix-Welti, M-A., Eléouët, J-F., Nevels, M., Randall, R. E. & Adamson, C. S., Feb 2018, In: Antiviral Research. 150, p. 79-92

    Research output: Contribution to journalArticlepeer-review

  2. Identification of novel inhibitors of the type I interferon induction pathway using cell-based high-throughput screening

    Gage, Z. O., Vasou, A., Gray, D., Randall, R. E. & Adamson, C. S., Oct 2016, In: Journal of Biomolecular Screening. 21, 9, p. 978-988 11 p.

    Research output: Contribution to journalArticlepeer-review

  3. Antiviral drug discovery: preparing for the next pandemic

    Adamson, C. S., Chibale, K., Goss, R., Jaspars, M., Newman, D. J. & Dorrington, R. A., 1 Feb 2021, In: Chemical Society Reviews. Advance Article, 9 p.

    Research output: Contribution to journalReview articlepeer-review

  4. Genetic lesions of type I interferon signalling in human antiviral immunity

    Duncan, C. J. A., Randall, R. E. & Hambleton, S., Jan 2021, In: Trends in Genetics. 37, 1, p. 46-58 13 p.

    Research output: Contribution to journalReview articlepeer-review

  5. Direct antiviral activity of interferon stimulated genes is responsible for resistance to paramyxoviruses in ISG15-deficient cells

    Holthaus, D., Vasou, A., Bamford, C., Andrejeva, J., Paulus, C., Randall, R. E., McLauchlan, J. & Hughes, D. J., 22 Jun 2020, In: The Journal of Immunology. 11 p., ji1901472.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. PLoS ONE (Journal)

    Joanna Louise Kershaw (Reviewer)

    18 Mar 2019

    Activity: Publication peer-review and editorial work typesPeer review of manuscripts

  2. PLoS One (Journal)

    Paula Jean Miles (Member of editorial board)

    2019

    Activity: Publication peer-review and editorial work typesPeer review of manuscripts

  3. PLoS ONE (Journal)

    Catharine Penelope Cross (Member of editorial board)

    1 Sep 2018 → …

    Activity: Publication peer-review and editorial work typesEditor of research journal

  4. PLoS ONE (Journal)

    Will Cresswell (Reviewer)

    23 May 2018

    Activity: Publication peer-review and editorial work typesPeer review of manuscripts

  5. PLoS ONE (Journal)

    Barbara Dritschel (Member of editorial board)

    May 2018 → …

    Activity: Publication peer-review and editorial work typesEditor of research journal

Related by journal

  1. Ecosystem engineers drive differing microbial community composition in intertidal estuarine sediments

    Wyness, A. J., Fortune, I., Blight, A. J., Browne, P., Hartley, M., Holden, M. & Paterson, D. M., 19 Feb 2021, In: PLoS ONE. 16, 2, 20 p., e0240952.

    Research output: Contribution to journalArticlepeer-review

  2. Performance evaluation of survival regression models in analysing Swedish dental implant complication data with frailty

    Fagbamigbe, A. F., Karlsson, K., Derks, J. & Petzold, M., 7 Jan 2021, In: PLoS ONE. 16, 1, 16 p., e0245111.

    Research output: Contribution to journalArticlepeer-review

  3. Young children share more under time pressure than after a delay

    Ploetner, M., Hepach, R., Over, H., Carpenter, M. & Tomasello, M., 16 Mar 2021, In: PLoS One. 16, 3, 10 p., e0248121.

    Research output: Contribution to journalArticlepeer-review

  4. Are in vitro and in silico approaches used appropriately for animal-based major depressive disorder research?

    Carvalho, C., Varela, S. A. M., Marques, T. A., Knight, A. & Vicente, L., 24 Jun 2020, In: PLoS ONE. 15, 6, 6 p., e0233954.

    Research output: Contribution to journalArticlepeer-review

  5. Artists on the edge of the world: an integrated approach to the study of Magdalenian engraved stone plaquettes from Jersey (Channel Islands)

    Bello, S. M., Blinkhorn, E., Needham, A., Bates, M., Duffy, S., Little, A., Pope, M., Scott, B., Shaw, A., Welch, M. D., Kinnaird, T., Millar, L., Robinson, R. & Conneller, C., 19 Aug 2020, In: PLoS ONE. 15, 8, 40 p., e0236875.

    Research output: Contribution to journalArticlepeer-review

ID: 158007622

Top